Dr Duncan Lascelles, Professor of Translational Pain Research and Management at North Carolina State University, will be delivering a webinar on switching between non-steroidal anti-inflammatories (NSAIDs) in canine patients on December 14th at 8pm.

Sponsored by Vetoquinol UK, manufacturers of Cimalgex, the webinar will consider the reasons for switching medications and the pharmacological properties which affect the decision process.

The session aims to better equip vets to make a more informed decision that balances risk of side effects with achieving optimal patient pain management and welfare. 

Duncan said: "NSAIDs remain a useful therapeutic tool for pain management in companion animals, particularly for conditions such as canine osteoarthritis.

"Although their benefits are clear at a group level, individual animal response can vary significantly; this is one of the key reasons why a clinician may switch a patient to a different NSAID, but due to concerns around adverse effects this often involves a washout period which can lead to gaps in pain management."

In the webinar, hosted on the WebinarVet platform, Duncan will give an overview of the ‘Whens, Whys and Hows’ of switching NSAIDs in dogs.

This will include findings from scientific studies and recommendations around switching safely, including when the washout period should be observed.  

Vetoquinol UK has also put together a free guide for vets on the topic, authored by Dr Lascelles.

Felicity Holford MRCVS, vet and Product Manager at Vetoquinol UK, said: "Vets are prescribing NSAIDs every day, but the existing information around switching and washout periods is limited and can be difficult to apply in practice.

"The webinar and guide will go into the science around the topic and the poster is there to act as a handy prompt for day-to-day use." 

Veterinary professionals can register their interest for the webinar here: https://bit.ly/Vetoquinol-WebinarVet 

The free NSAID guide and clinic poster are available here: https://bit.ly/NSAID-guide-Vetoquinol 

PS: Whilst you're here, take a moment to see our latest job opportunities for vets.